Chinese personal care ingredient manufacturer Bloomage has completed construction of a 30,000 square metre pilot-scale testing platform in Tianjin equipped with 64 pilot production lines.
The company says the facility is capable of accelerating the transition from research to large-scale production for both Bloomage and external industry partners, covering the entire biomanufacturing process including fermentation, purification and refining.
Adopting modular and drawer-style concepts to optimize the pilot production process, the centre supports pilot testing and small-scale commercial production of various bioactive raw materials, including cosmetic, pharmaceutical and food-grade products.
Pilot testing reduces product development risks and increases reliability by modelling real-world production and quality testing.
Bloomage says it is a crucial step in evaluating a product's feasibility and resolving its flaws before it reaches the market.
"Investing in the development of the pilot-scale testing platform is a key strategic initiative for Bloomage. It's a core component in empowering industries and bridging the gap between industry, academia, and research,” added CEO Zhan Yan.
“It will also further enhance the critical role of Bloomage as a pivotal link in the intermediate stages of supply chain management.”
The centre’s modular and flexible design allows for efficient transitions between different processes, easily supporting the production of multiple products in various forms.
This approach greatly optimizes equipment utilization and production efficiency while enhancing adaptability to meet diverse and customized R&D requirements.
Bloomage's pilot-scale testing platform is fully prepared for high-quality testing and production.
The purification stage adopts flexible modular designs to accommodate diverse product testing needs, while the refinement stage helps to ensure high-quality, safe products through rigorous anti-contamination measures.
The platform's intelligent command centre oversees pilot testing processes to provide real-time insights and optimizations.
The entire platform follows Industry 4.0 principles, streamlining processes using automation wherever possible to increase efficiency.
To help remove bottlenecks for innovation, Bloomage has adopted an open platform approach for its pilot-scale testing platform.
It offers comprehensive testing to assist external organizations, including academia, businesses and research institutions, in accelerating the commercialization of ideas while ensuring adherence to industry standards.
From equipment, to process, to technology, Bloomage's pilot-scale testing platform focuses on precision and standardization at every stage.
Additionally, more than 150 Bloomage experts can help prepare customers to reach market-readiness from scaling up to production.
By collaborating closely with internal R&D teams and strategic partners, the platform has successfully completed scaled-up testing of over ten products, it said.
